DEF: Ryan Specialty Exceeds $3B Revenue, Boosts Dividend & Repurchases

Sentiment:

Definitive Proxy Statement


Ryan Specialty Holdings, Inc. reports strong 2025 financial results with over $3 billion in revenue, 21% year-over-year growth, and announces a $300 million share repurchase program and an 8% dividend increase.

Worse than expectedThe 2025 Organic Revenue Growth Rate of 10.1% was below the target payout threshold of 13-15% for the Executive Incentive Corporate Plan, leading to a reduced payout for this metric.The 2025 Adjusted EBITDAC Margin of 30.97% was below the target payout threshold of 33.50-33.70% for the Executive Incentive Corporate Plan, resulting in a 0% payout for this metric.The Business Unit Adjusted Expense Margin of 54.80% was above the target payout threshold of 49.07-50.57% for Mr. Wuller's plan, leading to a 0% payout for this metric.The actual Short-Term Incentive (STI) award for NEOs on the Executive Incentive Corporate Plan was approximately 31.2% of target, and for Mr. Wuller, it was approximately 47.7% of target, indicating that overall executive incentive targets were not fully met.Patrick G. Ryan and Timothy W. Turner voluntarily forfeited their 2025 STI bonuses, which, while framed as a positive for other employees, implies that the top executives acknowledged that the company's performance did not warrant full bonus payouts at their level.

Summary

  • 2025 revenues surpassed $3 billion, marking a 21% increase year-over-year.
  • Achieved the 15th consecutive year of double-digit organic revenue growth and the 7th consecutive year of growing total revenue by over 20%.
  • Invested nearly $2.7 billion in 12 acquisitions over the last two years, significantly diversifying the platform.
  • Launched 'EMPOWER,' a three-year restructuring program aimed at streamlining operations, optimizing scale, accelerating data, technology, and AI strategies, and enhancing efficiencies.
  • Appointed Brendan Mulshine and Steve Keogh as Co-Presidents of the firm in October 2025.
  • The Board of Directors authorized an inaugural $300 million share repurchase program.
  • The Board also approved an 8% increase to the regular quarterly dividend.
  • Net Income for the year ended December 31, 2025, was $214,157,000.
  • The Organic Revenue Growth Rate for 2025 was 10.1% (using the new calculation methodology).
  • The Adjusted EBITDAC Margin for 2025 was 30.97%.
  • The Annual Meeting of Stockholders is scheduled for April 28, 2026, as a virtual-only meeting.
  • Proposals for the Annual Meeting include the election of five director nominees, ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026, and a non-binding advisory vote on named executive officer compensation.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to strong revenue growth, strategic acquisitions, and shareholder return initiatives, despite some executive incentive targets not being fully met, indicating robust operational execution in a challenging market.

Positives

  • Surpassed $3 billion in revenues in 2025, representing a strong 21% year-over-year increase.
  • Achieved the 15th consecutive year of double-digit organic revenue growth, demonstrating consistent performance.
  • Marked the 7th consecutive year of growing total revenue by over 20%, highlighting sustained expansion.
  • Invested nearly $2.7 billion in 12 acquisitions over the past two years, significantly diversifying the company's platform with new products, geographies, and capabilities.
  • The EMPOWER restructuring program is expected to create efficiencies, accelerate technology and AI strategies, and enable continued strategic investment in growth and talent.
  • Authorized an inaugural $300 million share repurchase program, reflecting confidence in the company's nearand long-term outlook.
  • Approved an 8% increase to the regular quarterly dividend, enhancing shareholder returns.
  • Strengthened the leadership team with the appointments of Brendan Mulshine and Steve Keogh as Co-Presidents.
  • Total Stockholder Return (TSR) increased 91% over the presented period, outperforming the S&P 500 Financials Sector Index, which increased 64% over the same period.
  • All executive officers and non-employee directors have either met or are within the five-year compliance period for stock ownership guidelines.

Negatives

  • The 2025 Organic Revenue Growth Rate of 10.1% was below the target payout threshold of 13-15% for the Executive Incentive Corporate Plan, resulting in a 3.3% payout of target for this metric.
  • The 2025 Adjusted EBITDAC Margin of 30.97% was below the target payout threshold of 33.50-33.70% for the Executive Incentive Corporate Plan, resulting in a 0% payout for this metric.
  • The Business Unit Adjusted Expense Margin of 54.80% was above the target payout threshold of 49.07-50.57% for Mr. Wuller's Executive Incentive Business Unit Plan, resulting in a 0% payout for this metric.
  • The total Short-Term Incentive (STI) award for NEOs on the Executive Incentive Corporate Plan was approximately 31.2% of target, and for Mr. Wuller, it was approximately 47.7% of target, indicating underperformance against incentive targets.
  • Patrick G. Ryan and Timothy W. Turner voluntarily forfeited their 2025 STI bonuses to provide additional funds for non-executive employees, which could be interpreted as a response to overall performance not fully meeting top-tier expectations.
  • Jeremiah R. Bickham separated from the company on October 8, 2025, under an involuntary termination without cause, transitioning to a non-employee strategic advisor role until January 1, 2026.

Risks

  • The EMPOWER restructuring program, while designed for efficiencies, introduces complexity with scale.
  • Incentive compensation arrangements are continuously reviewed to determine whether they encourage unnecessary or excessive risk-taking.
  • If an incumbent director is not elected, that director remains in office until a successor is duly elected and qualified or until the director's earlier resignation or removal.
  • The Director Nomination Agreement provides the Ryan Parties the right to nominate certain Board members based on their beneficial ownership, which could result in representation on the Board that is disproportionate to their beneficial ownership.
  • The company's business or reputation could be adversely impacted by acts or omissions constituting a breach of employment terms, felony convictions, or other lesser crimes or offenses by Named Executive Officers (NEOs).
  • Failure of NEOs to meet expected performance standards or to perform a substantial part of their duties could negatively impact the company.
  • Breach of fiduciary duty by NEOs is a potential risk.
  • Relocation of an NEO's office or primary work location more than 50 miles from the current location could constitute 'Good Reason' for termination, triggering severance benefits.
  • Patrick G. Ryan personally guaranteed up to $10.0 million of the LLC's financial obligations under an agency agreement, which could expose him to personal liability.
  • Indemnification for liabilities arising under the Securities Act, while provided to officers and directors, may be against public policy and therefore unenforceable.

Future Outlook

The company expects the EMPOWER restructuring program to create headroom for continued strategic investment in growth, top-tier talent, de novo formations, and innovation, which should enable it to maintain industry-leading growth in the years to come. The inaugural share repurchase program and increased dividend reflect the Board's confidence in both the nearand long-term outlook. Management anticipates driving significant additional value for stockholders by continuing to deliver differentiated value for brokers, agents, and insurance carrier trading partners.

Management Comments

  • Patrick G. Ryan: "Overall, 2025 was a strong year for Ryan Specialty, particularly considering the significant headwinds the industry faced."
  • Patrick G. Ryan: "Achieving these results at a time of challenging market conditions is an incredible testament to the resilience of our platform, the quality of our people, and the intentional diversification we've built over the past 15 years."
  • Patrick G. Ryan: "We built Ryan Specialty to excel through transitioning markets, not just for the easier years. Diversified specialties, diversified products, and diversified earnings, all backed by world-class talent, all by design."
  • Patrick G. Ryan: "This intentional diversification has opened the door to additional opportunities across all of our specialties, and we believe positions us well for a wide range of market outcomes."
  • Patrick G. Ryan: "I am incredibly proud of the depth, expertise, and determination of our entire team. Through their unwavering commitment to excellence, we will strive to continue to deliver differentiated value for our brokers, agents, and insurance carrier trading partners, which we expect will drive significant additional value for our stockholders."

Industry Context

StockSavvy.ai notes that Ryan Specialty's strong 2025 performance, including 21% revenue growth and consistent double-digit organic growth, demonstrates resilience and adaptability in a challenging industry market. The company's strategic diversification through 12 acquisitions and the launch of the EMPOWER program, focusing on streamlining operations and accelerating data, technology, and AI strategies, aligns with broader industry trends towards consolidation, efficiency, and technological advancement in the insurance and reinsurance sectors. The emphasis on top-tier talent and innovation positions Ryan Specialty to maintain a competitive edge and capitalize on evolving market dynamics.

Comparison to Industry Standards

  • Ryan Specialty's Total Stockholder Return (TSR) increased 91% over the presented period (from July 22, 2021, to December 31, 2025), significantly outperforming the S&P 500 Financials Sector Index, which increased 64% over the same period, indicating superior financial performance relative to a broad financial sector benchmark.
  • The company achieved its 15th consecutive year of double-digit organic revenue growth and its 7th consecutive year of growing total revenue by over 20%, which are strong indicators of sustained growth and market penetration compared to many industry peers.
  • The peer group used for executive compensation benchmarking includes major global insurance brokers and financial services firms such as Aon PLC, Arthur J. Gallagher & Co., Brown & Brown, Inc., Marsh & McLennan Companies, Inc., and Willis Towers Watson PLC, suggesting the company benchmarks its compensation and performance against leading industry players.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Co-President and Chief Revenue OfficerExecutive Vice President and Chief Revenue OfficerBrendan M. MulshineOctober 2025Promotion
Co-President and Chief Operating OfficerChief Operating OfficerStephen P. KeoghOctober 2025Promotion
Executive Chairman of the BoardChairman and Chief Executive OfficerPatrick G. RyanOctober 1, 2024Separation of CEO and Chairman roles
Chief Executive OfficerPresidentTimothy W. TurnerOctober 1, 2024Promotion; separation of CEO and Chairman roles
Chief Financial OfficerChief Accounting OfficerJanice M. HamiltonOctober 2024Promotion
PresidentJeremiah R. BickhamNAOctober 8, 2025Involuntary termination without cause; transitioned to non-employee strategic advisor until January 1, 2026
DirectorNAMichael G. BungertSeptember 2025Appointed to fill a vacancy upon the death of a director
Lead DirectorNAJohn W. Rogers, Jr.July 2025Appointment
DirectorD. Cameron FindlayNAJuly 11, 2025Death
DirectorRobert M. Le BlancNAFebruary 11, 2026Retirement

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board DeclassificationStockholders approved a proposal to declassify the Board and phase-in annual director elections, beginning with the 2026 Annual Meeting. The Board will no longer be classified by the 2028 annual meeting.2025 annual meeting of stockholdersEnhances accountability of directors to stockholders through annual elections.
Voting Standard for Director ElectionsImplemented a majority voting standard in uncontested director elections, with a plurality voting standard applying to contested director elections.2025 annual meeting of stockholdersIncreases director accountability by requiring a majority vote for election in uncontested elections.
Director Resignation PolicyAdopted a market standard resignation policy requiring an incumbent director who does not receive the requisite affirmative majority of votes for re-election to promptly tender their resignation to the Board, subject to Board acceptance.2025 annual meeting of stockholdersStrengthens corporate governance by providing a mechanism for addressing directors who fail to receive majority support.
Supermajority Voting Standard EliminationEliminated the springing supermajority voting standard for director removal and for amending Bylaws and certain certificate of incorporation provisions.2025 annual meeting of stockholdersReduces barriers for stockholders to effect changes, increasing responsiveness of the Board and management.
Class B Common Stock SunsetProvided for a specific outside date, September 30, 2029, by which the ten-to-one vote disparity of the Class B common stock to the Class A common stock would sunset.2025 annual meeting of stockholdersTransitions to a more equitable one-share, one-vote structure over time, enhancing governance for all Class A stockholders.
Stockholder Action by Written ConsentProvided stockholders with the ability to take action by written consent.2025 annual meeting of stockholdersEmpowers stockholders to act outside of annual meetings, increasing their influence.
Stockholder Right to Call Special MeetingsProvided stockholders with the ability to call special meetings of stockholders, with qualifications and procedures specifying ownership percentage and information requirements.2025 annual meeting of stockholdersEnhances stockholder rights by allowing them to convene special meetings on important matters.
Officer ExculpationProvided for the exculpation of certain officers of the Company to the fullest extent provided under Delaware law.2025 annual meeting of stockholdersProtects officers from liability for certain breaches of fiduciary duty, potentially aiding in talent attraction and retention.
Lead Director AppointmentJohn W. Rogers, Jr. appointed Lead Director, presiding at executive sessions of independent directors and other Board meetings when the Chairman is absent.July 2025Strengthens independent oversight and provides a clear independent voice on the Board.
Separation of Chairman and CEO RolesPatrick G. Ryan transitioned from Chairman and CEO to Executive Chairman, and Timothy W. Turner assumed the CEO role, effectively separating the roles.October 1, 2024Enhances corporate governance by separating leadership roles, allowing for distinct focus on strategic oversight (Chairman) and operational execution (CEO).
Clawback PolicyAdopted a Clawback Policy complying with Section 10D of the Exchange Act and NYSE listing standards, requiring recovery of erroneously awarded incentive compensation from Section 16 Officers in case of accounting restatements, regardless of misconduct.NA (policy adopted)Aligns executive compensation with accurate financial reporting and enhances accountability.
Anti-Hedging and Anti-Pledging PoliciesProhibits directors and employees from pledging Company shares and engaging in hedging transactions with respect to Company securities, except as explicitly approved.NA (policy adopted)Reduces potential conflicts of interest and encourages long-term alignment with stockholder interests.

Related Party Transactions

  • Ryan Investment Holdings, LLC (RIH) is an investment holding company in which the LLC holds a 47% interest and Geneva-Ryan Holdings, LLC (GRH) holds a 53% interest. GRH aggregates investment funds from Patrick G. Ryan, Patrick G. Ryan, Jr., and other affiliated investors. RIH has a 50% non-controlling interest in Geneva Re Partners, LLC (GRP).
  • Patrick G. Ryan has committed to personally fund additional capital contributions to GRP, receiving promissory notes from RIH for such contributions.
  • The Company had $0.3 million due from Geneva Re under a service agreement for administrative services as of December 31, 2025.
  • Ryan Re (a wholly owned subsidiary) earned $1.6 million in revenue from Geneva Re for underwriting and administrative services in 2025, with $0.8 million receivable as of December 31, 2025.
  • Ryan Re incurred $11.7 million in expense during 2025 and had $6.4 million in prepaid expenses as of December 31, 2025, related to subcontracted services from Geneva Re for a third-party insurer.
  • The Company made a payment of $3.7 million to Patrick G. Ryan and his wife on December 29, 2025, to settle outstanding preferred equity in Ryan Re, including $0.4 million in accrued interest.
  • The Company chartered executive jets from Executive Jet Management (EJM), with Mr. Ryan indirectly owning aircraft leased to EJM. The Company paid $0.9 million in 2025 for business usage, of which Mr. Ryan indirectly received $0.5 million in remuneration. The Company receives a discount when chartering Mr. Ryan's aircraft.
  • Patrick G. Ryan personally guaranteed up to $10.0 million of the LLC's financial obligations under an agency agreement in April 2021, without consideration from the Company.
  • The Company entered into a Registration Rights Agreement with the Ryan Parties (Patrick G. Ryan and family) and Onex, granting them rights to request registration of their capital stock. Onex sold its remaining Registrable Securities in 2025.
  • The Company entered into a Tax Receivable Agreement with current and certain former LLC Unitholders, providing for payments of 85% of certain tax benefits realized by the Company.
  • The Director Nomination Agreement provides the Ryan Parties the right to nominate certain Board members based on their beneficial ownership, potentially resulting in disproportionate representation. After Robert M. Le Blanc's retirement, the Ryan Parties became eligible to nominate all Board nominees.
  • Indemnification agreements are in place with officers and directors, providing contractual rights to indemnification and expense advancement.
  • Brendan M. Mulshine's spouse is the niece of Patrick G. Ryan and a cousin of Patrick G. Ryan, Jr.
  • Patrick G. Ryan, Jr., a director, is the son of Patrick G. Ryan.

Stakeholder Impact

  • **Shareholders**: Benefit from strong revenue growth, strategic diversification, the inaugural share repurchase program, and an increased dividend. Enhanced corporate governance measures, including board declassification, majority voting, and expanded stockholder rights, are expected to increase accountability and influence. The long-term incentive plans and EMPOWER program aim to drive sustained value creation.
  • **Employees**: Benefit from a culture of meritocracy, inclusion, and empowerment. The executive compensation structure is designed to attract and retain top talent. Non-executive employees received additional bonus funds due to Messrs. Ryan and Turner forfeiting their 2025 STI bonuses.
  • **Customers/Clients/Trading Partners**: The EMPOWER program, focused on streamlining operations and accelerating technology, is expected to lead to enhanced efficiencies and differentiated value for brokers, agents, and insurance carrier trading partners.
  • **Management**: New leadership appointments strengthen the executive team. Executive compensation is tied to performance, with stock ownership guidelines aligning interests with shareholders. Severance plans provide security during transitions.
  • **Regulatory Authorities**: The company's adherence to SEC and NYSE regulations, including new clawback and anti-hedging/pledging policies, demonstrates a commitment to compliance and good governance.

Next Steps

  • The Annual Meeting of Stockholders will be held on April 28, 2026, to elect directors, ratify the independent auditor, and vote on executive compensation.
  • The EMPOWER three-year restructuring program will continue to streamline operations, optimize scale, and accelerate data, technology, and AI strategies.
  • The company plans for continued strategic investment in growth, top-tier talent, de novo formations, and innovation.
  • Final voting results for the Annual Meeting will be announced by filing a Current Report on Form 8-K within four business days after the meeting.
  • The Board will be fully declassified by the 2028 annual meeting of stockholders, with all directors standing for annual election.
  • The ten-to-one vote disparity of Class B common stock will sunset by September 30, 2029.
  • Executive officers and non-employee directors are within their five-year compliance period to meet stock ownership guidelines.

Key Dates

DateDescription
2010Ryan Specialty founded.
June 13, 2019Ryan Re entered into a services agreement with Geneva Re.
August 2019Francesca Cornelli became dean of Northwestern University's Kellogg School of Management.
September 2020All Risks, Ltd. acquired by Ryan Specialty.
March 2021Timothy W. Turner became President.
April 20, 2021New Ryan Specialty, LLC formed as an intermediate holding company.
April 21, 2021Stock ownership guidelines adopted for non-employee directors.
April 2021Patrick G. Ryan personally guaranteed up to $10.0 million of the LLC's financial obligations.
July 21, 2021Company's Initial Public Offering (IPO).
July 22, 2021First trading date of Class A common stock after IPO.
September 30, 2021Equity interest holders of Ryan Specialty, LLC exchanged equity interests for LLC Common Units in New LLC.
October 2021Benjamin M. Wuller became CEO of Ryan Specialty Underwriting Managers (RSUM).
June 7, 2022Stock ownership guidelines adopted for executive officers.
April 2, 2023Ryan Re entered into a services agreement with Geneva Re for subcontracted services.
April 2023Onex sold its remaining shares of Class A common stock, losing its board nomination right.
July 2023Francesca Cornelli joined the Board.
August 2023Michael L. Conklin became Executive Vice President and Chief Human Resources Officer.
October 2023Anthony J. Kuczinski joined the Board.
January 2024Patrick G. Ryan, Jr. joined the Board.
March 2024Performance-based awards (PLUs/PSUs) granted to NEOs (excluding Mr. Ryan, Ms. Hamilton, and Mr. Keogh).
October 1, 2024Patrick G. Ryan became Executive Chairman; Timothy W. Turner assumed the role of CEO; Janice M. Hamilton became CFO.
November 2024Janice M. Hamilton received a grant of 2024 PSUs.
December 31, 2024Date used for global employee population for median employee calculation.
February 2025Benjamin M. Wuller ceased serving as RSUM's President.
May 1, 2025Stephen P. Keogh began his employment.
May 6, 2025Stephen P. Keogh received a performance-based award (2025 PSUs).
May 30, 2025Non-employee directors received grants of Restricted Stock Units (RSUs).
July 2025John W. Rogers, Jr. appointed Lead Director.
July 11, 2025D. Cameron Findlay passed away.
September 2025Michael G. Bungert joined the Board.
October 8, 2025Jeremiah R. Bickham separated from the Company.
October 2025Brendan M. Mulshine and Stephen P. Keogh became Co-Presidents.
October 2025The Board completed its most recent annual self-evaluation.
October 2025The Board approved the payment of all unreturned capital to retire outstanding preferred equity held by Mr. Ryan and his wife.
December 29, 2025The Company made a payment of $3.7 million to Patrick G. Ryan and his wife to settle outstanding preferred equity.
December 31, 2025Fiscal year end.
January 1, 2026Non-employee director compensation policy changes became effective.
January 1, 2026Jeremiah R. Bickham's role as a non-employee strategic advisor to the Company ended.
February 11, 2026Robert M. Le Blanc retired from the Board.
March 2, 2026Record Date for the 2026 Annual Meeting of Stockholders.
March 17, 2026Proxy Statement dated and first sent to stockholders.
April 1, 2026First tranche of 2023 Class C Units vest for Mr. Wuller.
April 21, 2026Deadline for non-employee directors (serving at policy adoption) to meet stock ownership guidelines.
April 28, 20262026 Annual Meeting of Stockholders.
July 22, 2026Reload Class C Units vest for Ms. Hamilton and Mr. Bickham.
July 22, 2026Staking RLUs vest for Ms. Hamilton.
July 22, 2026Staking Class C Units vest for Mr. Bickham.
January 28, 2027Latest date for stockholder nominations for the 2027 annual meeting (assuming no change in meeting date).
February 27, 2027Latest date for universal proxy rule notice for the 2027 annual meeting (assuming no change in meeting date).
April 1, 2027Second tranche of 2023 Class C Units vest for Mr. Wuller.
April 1, 2028Third tranche of 2023 Class C Units vest for Mr. Wuller.
2028The Board will no longer be classified by the annual meeting of stockholders.
April 1, 2029Certification Date for PLUs and 2024 PSUs, subject to performance metrics and continued employment through January 1, 2029.
April 1, 2029Fourth tranche of 2023 Class C Units vest for Mr. Wuller.
September 30, 2029Sunset date for the ten-to-one vote disparity of the Class B common stock to the Class A common stock.
April 1, 2030Vesting Date for 2025 PSUs, subject to performance targets and continued employment.
April 1, 2030Fifth tranche of 2023 Class C Units vest for Mr. Wuller.
July 22, 2031Final 30% of Staking RLUs and Staking Class C Units vest.

Recommendation

hold

Ryan Specialty demonstrates strong operational performance with consistent revenue growth and strategic acquisitions, indicating a robust business model in a challenging market. The new share repurchase program and dividend increase are positive signals for shareholder returns. However, the underperformance against executive incentive targets for organic revenue growth and Adjusted EBITDAC margin suggests that while overall results are good, they did not fully meet internal stretch goals. The extensive corporate governance enhancements are a long-term positive. Given the strong foundation and strategic initiatives, but also the slight miss on some internal performance metrics for executive compensation, a 'hold' recommendation is appropriate, awaiting further evidence of the EMPOWER program's impact and sustained outperformance against all internal targets.

Keywords

Ryan Specialty, SEC filing, DEF 14A, proxy statement, financial results, revenue growth, organic growth, acquisitions, share repurchase, dividend increase, executive compensation, corporate governance, board of directors, risk management, EMPOWER program, insurance, reinsurance, specialty insurance, MGA, underwriting, broker, financial services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.